Clinical and serological records of 865 patients with confirmed autoimmune haemolysis (AIH)-a much larger series than any previously reported-were critically reviewed and analysed. A proposed new classification for AIH based on serological findings differs from traditional classifications in that a new category of "mixed" AIH has been defined in which both "warm" and "cold" autoantibodies are present, and both are capable of causing haemolysis. Patients in this mixed group tend to have severe disease that may run a chronic intermittent course. The presentation of cold agglutinin disease is much more variable than has been seen in previous studies, haemolysis due to low titre autoantibodies being common. The AIH associated with pregnancy, usually considered as being of bad prognosis, is often mild and self limiting in the absence of other associated disorders.
Introduction
Autoimmune haemolysis (AIH) is a well-recognised clinical problem requiring skilled management and investigation. It is rare, however, for any one hospital to see more than five or six new cases a year. The Trent Regional Blood Transfusion Centre, which serves a population of roughly 4-7 million people in an area of 6500 square miles (16 828 sq kin), acts as an immunohaematology reference centre for hospitals within the Trent Region and South Humberside. Blood samples from patients with AIH, or in whom this diagnosis is suspected, are referred to this centre and have provided a unique opportunity to study a great many cases.
Materials and methods
Examination of the results of investigations on blood samples referred to the immunohaematology reference laboratory from September 1961 to 31 December 1980 showed that 865 patients were confirmed to have AIH. The clinical records and serological worksheets were analysed in detail. Patients found to have paroxysmal nocturnal haemoglobinuria, glucose 6-phosphate dehydrogenase (G6PD) deficiency, haemolytic anaemia associated with polyagglutinable cells, or in whom there was insufficient evidence to warrant a diagnosis of AIH were not considered further.
Full clinical details, with particular attention to drug history and disorders known to be associated with autoimmune haemolytic anaemia (AIHA), were recorded when possible. The relevant haematological, serological, and biochemical findings of the referring hospital and the time of year of presentation were noted. Male patients with ages ranging from 5 months to 97 years and female patients ages ranging from 2 years to 89 years were grouped by age into decades. Details of the total male and female population at risk during the period of study were obtained from the medical statistics department at the Trent Regional Health Authority.
Whenever possible, examination was performed on serum from blood that had been kept at 37°C during clotting and separation, and on red cells taken from whole blood anticoagulated with EDTA. The following investigations were routinely carried out:
(1) ABO and rhesus (Rh) genotyping.
(2) Direct antiglobulin tests using broad-spectrum and anticomplement reagents.
(3) Antibody investigations.
(a) Antibodies were detected in serum using saline, albumin, papain, and by antihuman globulin methods at 37°C and in saline at 18°C. Other tests, including direct antiglobulin tests using specific reagents (anti-IgA, IgG, IgM, C3d, C3b, C4), antibody concentration using dialysis, and antibody separation using gel chromatography with Sephadex G-200, have been introduced since the survey began and will be reported where relevant.
Patients confirmed to have AIH were classified by disease association and divided into groups depending on whether the antibody was mainly active at 37°C ("warm" AIH), at 18°C ("cold" AIH), or into a group in whom both warm and cold antibodies were found and the serological reactions were such that both antibodies were considered capable of causing the haemolysis ("mixed" AIH). Age at the time of presentation is shown in the figure: the early peak of cases with cold AIH is mainly due to patients with paroxysmal cold haemoglobinuria. In all groups, with the exception of those with paroxysmal cold haemoglobinuria, there was a slight female predominance (the male :female ratio varied from 1:1-15 to 1:1 33). tlncludes one patient with drug-associated mixed AIH.
Results
The time of presentation was not related to the season of the year. Serological findings are shown in tables II, III, and IV. The autoantibodies (serum or eluate) showed evidence of blood group specificity in many instances (table IV) ; this was more obvious in patients with cold AIH. The specificity was rarely simple and, in nearly every case, pan-reacting antibodies could be detected by at least one method.
In cases associated with cold autoantibodies a small group of patients with paroxysmal cold haemoglobinuria could be separated on the basis of the serological reactions. Fifteen patients were found to have paroxysmal cold haemoglobinuria, confirmed by positive indirect Donath-Landsteiner tests (table III) , and a further two were found during this review who, in retrospect, were almost certainly suffering from paroxysmal cold haemoglobinuria but in whom full serology was not carried out. Twelve patients were male and five female; 13 were under 10 years and only one over 40. In 16 instances the disease followed an acute course and in one (a patient aged 32) it was chronic; in the patients with acute disease the result of the direct antiglobulin test was weakly positive whereas in the patient with chronic paroxysmal cold haemoglobinuria the result of the direct antiglobulin test was negative (table II) . Positive Wassermann complement fixation tests for syphilis were found in three patients, but in no case was a luetic infection confirmed. Reaction pattern of haemolysins 18 C and 37 C at pH 6 
Discussion
Although autoimmune haemolytic anaemia is usually thought of as a well-defined clinical syndrome, the more closely cases are examined the more obvious it becomes that anaemia due to autoimmune haemolysis merely represents an extreme of a fundamental disturbance in immune homeostatis. As haemolysis may be present in the absence of anaemia we prefer the term autoimmune haemolysis, which refers to when a patient produces a protein that attaches to the autologous red cell and there is evidence that this causes a shortening of the red cell life span. This view is in broad agreement with those of other authors.'1 Like all definitions, it has its limitations, diagnosis depending ultimately on the sensitivity of serological reactions and the estimation of the red cell life span in an often complicated situation. All the cases presented here (with the exception of some associated with cx-methyldopa treatment-to be discussed later) had good evidence of AIH.
More patients took part in this series than in other similar studies. -6 During this 18-year study our immunohaematology service has developed, and more sensitive and specific techniques have been introduced; a particular example has been the development of the direct antiglobulin test from the original tile method using "broad spectrum" reagents, with and without absorption with IgG, to the current tube techniques using monospecific antiglobulin and anticomplement reagents. These developments are still continuing and currently include the chromatographic separation of the warm and cold antibody components in cases of mixed AIH.
When the incidence of AIH is considered per 100 000 of the population at risk it is seen that the disorder increases dramatically after 41-50 years, and the incidence continues to rise (fig) . Using these parameters, the peaks of incidence in other series are seen to be just a reflection of the population at risk.6 Pirofsky5 found a one in 80 000 minimum annual incidence of AIHA, which is of the same order as the present series; he also found an equal sex ratio that he attributed to the sex ratio of the underlying disorders-idiopathic AIHA and that associated with systemic lupus erythematosus were more common in women and AIHA associated with lymphoma and chronic lymphocytic leukaemia were more common in men. Our results show more women in all serological groups except those with paroxysmal cold haemoglobinuria. Cases of acute paroxysmal cold haemoglobinuria were also the exception to the increased incidence with age, patients usually presenting in childhood, often after a viral type infection; these findings were similar to those of other series, but male predominance was not reported.4 7 8
The concept of secondary AIH is complicated. It may mean that the AIH is associated with the other disease with a greater frequency than can be explained by chance alone, or that the AIH resolves when the associated disease is corrected-for instance, ovarian dermoid cysts-or that the two disorders are different parts of a complex immunologically mediated multisystem disorder. The present results show that AIH associated with cold antibodies has a much more variable picture than the usually portrayed characteristic clinical syndrome with high titre cold agglutinins of wide thermal amplitude.1 28 Roughly 50), only of our series (idiopathic and secondary) fitted into the typical cold agglutinin syndrome, the remainder showed low titre cold agglutinins associated with varying degrees of haemolysis. These findings are in agreement with those of some other workers who emphasised the importance of the thermal amplitude of the antibody in the development of haemolysis, activity at 30'C or above in albumin being the critical test for a diagnosis of cold agglutinin disease.4 13-16 Cold antibodies acting at 30C'C or above were shown (using the less sensitive saline technique) in nearly all of the present cases.
Drug-induced cases of AIH were almost entirely due to xmethyldopa. Our series includes those patients in whom autoreacting and usually pan-reacting antibodies were present; cases with a positive direct antiglobulin test result but without circulating antibody were excluded as the consensus opinion is that these cases no not haemolyse.4 Some patients also had other conditions that may be associated with AIH but in these cases it was thought that the drug was the main aetiological agent. Our findings, on the whole, were similar to those of other reports, with warm-type AIH and IgG alone coating the red cells (except in a few cases where a complement component was also present).1 2 4 81,18 The one patient with mixed type AIH was interesting as she had been taking oc-methyldopa for 12 years, initially 250 mg twice daily, but this had been doubled 11 months before presentation; the cold antibody component was of low titre and showed anti-I specificity. Whether the cold antibody was coincident was not known, but the severe haemolysis rapidly stopped after cessation of x-methyldopa and a short course of steroids. Despite a positive direct antiglobulin test result and the presence of circulating antibody some patients taking o.-methyldopa do not have evidence of a haemolytic anaemia.4 8 18 They may have mild compensated haemolysis, but in a few cases the red cell life span has been measured and in some instances found to be normal4 ' 9; possibly a few of our cases fit into this category. Measurement of red cell life span has rarely been carried out in patients with AIH, but these findings suggest it should become an important definitive investigation in the future. AIH due to mefenamic acid (Ponstan) is rare, and our one case, which was well documented, occurred in a patient with chronic granulocytic leukaemia; the haemolysis rapidly ceased when the drug was stopped.
AIHA associated with pregnancy is rare. The present series, which includes only those patients who presented during pregnancy or in the immediate postnatal period, is the largest number of cases examined by one group; patients with preexisting systemic lupus erythematosus or other disorders that might have caused the AIH and patients with known AIH who become pregnant are excluded. In most instances the disease was mild and in six was initially discovered at routine antenatal testing; only three patients had a severe haemolytic anaemia. Details of the babies' clinical condition were not complete, but nine (including one set of twins) are known to have been well and only two were ill, one of the latter suffering from haemolytic disease of the newborn due to anti-Rh D. These findings differ from those of previous reports,4 2 which concluded that AIHA during pregnancy is often severe and life threatening to the mother in 40-50"O of cases and causes stillbirth or postpartum haemolytic anaemia in 35-40°of infants. These reports, however, did not distinguish pregnancy occurring in patients with known AIHA from AIHA arising during pregnancy.
Two patients undergoing renal dialysis were found to have cold AIH due to auto anti N; the haemolysis was mild in the patient with an MN genotype and moderate in the other with NN. These cases were similar to those of Clinical and laboratory studies in a patient whose rheumatoid arthritis appeared to be exacerbated by dairy produce showed that challenge with milk and cheese resulted in a pronounced increase in synovitis and changes in immune complexes, IgE antibodies, and heat-damaged red cell clearance rates. Exclusion of dairy produce from the diet produced a considerable improvement in her previously aggressive disease.
Despite an increasing interest in the potentially pathogenic effects of food allergy and despite the conviction of innumerable patients with rheumatoid arthritis that certain foods exacerbate their disease, little scientific attention has been paid to the relation between ingested food antigen and rheumatoid disease activity. Recent studies have shown that the absorption of food antigen may be associated with the development of circulating immune complexes in some patients with IgA deficiency or with food antigen sensitivity as well as in certain normal individuals,'-3 and that certain non-human proteins such as casein may become deposited in the skin of such people.4
As part of a larger study of the effects of certain food proteins on immunological measures in rheumatic disease, we have recently observed a patient in whom the ingestion of cheese and other dairy products had an immediate and profound effect on her clinical and immunological state. Restriction of these foods produced a prolonged improvement in the patient's previously unresponsive arthritis. Conventional treatment with salicylates and non-steroidal anti-inflammatory agents had failed. Both gold and penicillamine treatment had had to be discontinued owing to mucocutaneous side effects, and prednisolone 10 mg daily (which she was still taking) had failed to relieve the intense synovitis and stiffness. Plasma exchange was tried, and although she obtained some relief this benefit was short lived. Azathioprine was also tried but was stopped because of intestinal upset.
The patient gave a history of multiple drug allergies, including sensitivity to penicillin, as well as the toxic manifestations of gold and penicillamine treatment. She had developed severe gastrointestinal discomfort associated with aspirin, indomethacin, and azathioprine, and rashes related to Elastoplast and detergents. At no time had she experienced respiratory symptoms on exposure to these chemicals, and she had never noticed an exacerbation of her arthritis after such exposure. Her mother (who also has rheumatoid arthritis) was similarly reactive to Elastoplast, penicillin, detergents, and aspirin, and also nickel. Her sister and niece both have asthma.
On examination, she was a pale, unwell young woman with widespread intense synovitis affecting both large and small joints symmetrically. Stiffness as well as fatigue lasted for several hours each day. There were no nodules. There was dryness of the eyes and mouth and a dry Schirmer's test. Grip strengths were weak (110 mm with the left hand and 120 mm with the right hand) and the Ritchie index of articular activity5 was high at 42. Investigations showed a normochromic, normocytic anaemia of 10 5 g/dl, an erythrocyte sedimentation rate of 110 mm in the first hour, and normal immunoglobulins. IgM rheumatoid factor tests (Latex and sheep cell agglutination) were negative on numerous occasions. Circulating immune complexes as measured by the Clq binding method6 and the rheumatoid factor binding method were present in a titre of greater than 250 ,ug equivalents of heat-aggregated human IgG. No cryoprecipitate was detected. C3 concentrations were normal at 96% of normal human serum, and total haemolytic complement activity was 60-90% of normal human serum. Estimates of reticuloendothelial function using clearance of heat-damaged red cells7 showed prolonged clearance on more than one occasion. Radiographs showed many erosions in the carpus and metacarpal phalangeal joints as well as proximal interphalangeal joints and metatarsal phalangeal joints.
TREATMENT AND PROGRESS
Since her early 20s the patient had had a passion for cheese, consuming up to 1 lb (0 4 kg) a day. Although there was no clear history of allergy or diarrhoea after eating cheese she agreed to try the effect of restricting dairy produce, with the elimination of milk,
